Showing results 4 to 8 of 8
< previous
| Issue Date | Title | Author(s) |
| 2024 | Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma | Luo, Fei; Zhong, Qiu-Zi; Liu, Xin; Hou, Xiao-Rong; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong |
| Jun-2021 | Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Yang, Yong; Wang, Ying; Liu, Xin; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Hu, Chen; Qi, Shu-Nan; Li, Ye-Xiong |
| 2018 | Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) | Deng, Xiu-Wen; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Su, Hang; Wang, Ying; He, Xia; Xu, Li-Ming; Yuan, Zhi-Yong; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Zhang, Yu-Jing; Zhu, Yuan; Cao, Jian-Zhong; Lan, Sheng-Min; Dong, Mei; Qi, Shu-Nan; Yang, Yong; Li, Ye-Xiong |
| Sep-2020 | Risk-based, response-adapted therapy for early-stage extranodal nasal-typeNK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study | Qi, Shu-Nan; Yang, Yong; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Su, Hang; Song, Yu-Qin; Zhu, Jun; Hu, Chen; Li, Ye-Xiong |
| Mar-2020 | Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Chen, Si-Ye; Yang, Yong; Qi, Shu-Nan; Wang, Ying; Hu, Chen; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhang, Yu-Jing; Zhu, Yuan; Cao, Jian-Zhong; Lan, Sheng-Min; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Yahalom, Joachim; Tsang, Richard; Song, Yu-Qin; Zhu, Jun; Su, Hang; Li, Ye-Xiong |
